Envestnet Asset Management Inc Humacyte, Inc. Transaction History
Envestnet Asset Management Inc
- $324 Billion
- Q3 2025
A detailed history of Envestnet Asset Management Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 26,211 shares of HUMA stock, worth $33,812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,211Holding current value
$33,812% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
160Shares Held
50.6MCall Options Held
935KPut Options Held
808K-
Vanguard Group Inc Valley Forge, PA7.52MShares$9.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$9.21 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$5.66 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$3.99 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.64MShares$3.4 Million0.01% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $133M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...